These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8866773)

  • 21. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Distinguishing depressive from nondepressive patients in schizophrenia in terms of symptomatology].
    Aydemir O; Esen Danaci A; Pirildar S
    Turk Psikiyatri Derg; 2002; 13(3):173-8. PubMed ID: 12794651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary and secondary negative symptoms: a useful differentiation? An empirical study].
    Barnett W; Mundt C; Richter P
    Nervenarzt; 1996 Jul; 67(7):558-63. PubMed ID: 8927194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance.
    Lambert M; Schimmelmann BG; Karow A; Naber D
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S181-90. PubMed ID: 14677077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series.
    Christodoulides T; Dudley R; Brown S; Turkington D; Beck AT
    Psychol Psychother; 2008 Jun; 81(Pt 2):199-207. PubMed ID: 18230197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Depression scales in schizophrenia: a critical review].
    Reine G; Bernard D; Lancon C
    Encephale; 1998; 24(6):530-40. PubMed ID: 9949936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms.
    Ruhrmann S; Kissling W; Lesch OM; Schmauss M; Seemann U; Philipp M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1012-22. PubMed ID: 17412473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The positive-negative dimension in schizophrenia: its validity and significance.
    Kay SR; Opler LA
    Psychiatr Dev; 1987; 5(2):79-103. PubMed ID: 2888108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
    Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
    Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
    Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The psychopathology of schizophrenia: an integrated view on positive symptoms and negative symptoms.
    Möller HJ
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():57-64. PubMed ID: 8866766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [J. Delay hypothymic disorder. Current aspects and pertinence of the concept in schizophrenic states].
    Dollfus S; Petit M
    Encephale; 1993; 19(2):109-15. PubMed ID: 8275896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empirical validation of primary negative symptoms: independence from effects of medication and psychosis.
    Kelley ME; van Kammen DP; Allen DN
    Am J Psychiatry; 1999 Mar; 156(3):406-11. PubMed ID: 10080556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subjective symptoms: part of the negative syndrome of schizophrenia?
    Bitter I; Jaeger J; Agdeppa J; Volavka J
    Psychopharmacol Bull; 1989; 25(2):180-4. PubMed ID: 2574892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Depression in schizophrenia. Comments on possibilities to use fluoxetine].
    Jarema M
    Psychiatr Pol; 1996; 30(1):75-86. PubMed ID: 8722241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.